Glucose uptake was measured in fully differentiated C2C12 cells using a non-radioactive fluorometric assay, as previously described (Leira et al., 2002; Zou et al., 2005; Kanwal et al., 2012). Briefly, following differentiation in 6 well plates, cells were serum starved in growth media for 2 h and cells were treated with either vehicle control, IL-15 100 ng/ml, insulin (100 nM), a STAT3 inhibitor (100 μM; S31-201; Sigma), or IL-15 + S31-20 with or without 50 μM 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) (Cayman Chemical) in Krebs-Henseleit buffer containing 0.1% fatty acid free BSA (Sigma) and 2000 mg/L of glucose at 37°C with 5% CO2(Siddiquee et al., 2007; Kelly et al., 2010). Following 2 h, the cells were lysed in PBS-Triton-X100 buffer and florescence was measured using a microplate reader with excitation 488 nm and emission 520 nm. The concentration of NBDG uptake was calculated from a standard curve of NBDG in lysis buffer. Values were normalized to the protein content present in the cell lysates.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.